Ranibizumab Plus Indomethacin

NCT03261635 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Macular Edema

Interventions

DRUG: Ranibizumab Injection
DRUG: Indomethacin

Sponsor

Università degli Studi di Brescia